What are the limitations of the poem patient oriented eczema measure?

While the poem patient oriented eczema measure is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the poem patient oriented eczema measure to ensure safe bedside use and optimal diagnostic accuracy.

How does the poem patient oriented eczema measure compare to other Dermatology scores?

The poem patient oriented eczema measure is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the poem patient oriented eczema measure free to use?

Yes. OpiCalc provides the poem patient oriented eczema measure completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

To measure atopic eczema severity directly from the patient’s perspective.
Standardized monitoring for atopic dermatitis (AD) in clinical practice and trials over the previous 7 days.

CLINICAL INSIGHT

How it Works

Scoring Logic

Consists of 7 questions about frequency of symptoms over the past week.
Symptoms evaluated: Itching, sleep disturbance, bleeding, weeping/oozing, cracking, flaking, feeling dry/rough.
Frequency scoring: No days (0), 1-2 days (1), 3-4 days (2), 5-6 days (3), Every day (4).

Interpretation

Score	Severity
0-2	Clear or almost clear
3-7	Mild eczema
8-16	Moderate eczema
17-24	Severe eczema
25-28	Very severe eczema

CLINICAL INSIGHT

Practical Pearls

Clinical Pearls

Essential for capturing subjective disease burden (itch and sleep loss) that objective scores like EASI notoriously miss.
Requires the patient or parent/guardian to complete it independently prior to the consultation for maximum validity.

CLINICAL INSIGHT

Next Steps

Clinical Follow-up

A change of 3.4 points (often rounded to 3 or 4) is generally considered the Minimal Clinically Important Difference (MCID).

CLINICAL INSIGHT

Evidence Base

Primary Reference

Score

Severity

0-2

Clear or almost clear

3-7

Mild eczema

8-16

Moderate eczema

17-24

Severe eczema

25-28

Very severe eczema

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Use

How it Works

Scoring Logic

Interpretation

Practical Pearls

Clinical Pearls

Next Steps

Clinical Follow-up

Evidence Base

Primary Reference

SCORAD

Clinical Reference Hub

When to Use

When to Use

How it Works

Formula

Variables

Practical Pearls

Clinical Pearls

Next Steps

Interpretation

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Use

How it Works

Scoring Logic

Interpretation

Practical Pearls

Clinical Pearls

Next Steps

Clinical Follow-up

Evidence Base

Primary Reference

SCORAD

Clinical Reference Hub

When to Use

When to Use

How it Works

Formula

Variables

Practical Pearls

Clinical Pearls

Next Steps

Interpretation